Percutaneous coronary intervention
Image-guided therapy

Percutaneous coronary intervention

Transform complex PCI procedures into confident care

Integrate every step of the PCI procedure with advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services. All work intelligently together to efficiently support every step of coronary procedures from diagnosis to restoring vessel patency.

Demonstrated results in percutaneous coronary intervention

  1. 28.8%

    reduction in contrast agent with Dynamic Coronary Roadmap1

    28.8%

    reduction in contrast agent with Dynamic Coronary Roadmap1

    Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.

    Download
  2. 85%

    believe TSM control of HEMO visualizations improves workflow.2

    85%

    believe TSM control of HEMO visualizations improves workflow.2

    A usability study revealed that 85% of users believe the Azurion TSM control of HEMO visualizations and measurements improves workflow.2 To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by 33 participants.

  3. $896

    saved per patient with Philips iFR compared to FFR.3

    $896

    saved per patient with Philips iFR compared to FFR.3

    An analysis to assess a cost-minimization of iFR-guided compared with FFR-guided revascularization demonstrated a cost saving per patient of $681 (95% CI: $641 - $723) in the Nordic setting and $1024 (95% CI: $934 - $1114) in the US, when using iFR-guided revascularization.3

Stay close to the heart with Philips solutions

Perform ultra-low contrast PCI procedures with confidence. Philips percutaneous coronary intervention solutions co-register instantaneous blood flow measurements and/or intravascular ultrasound (IVUS) images onto real-time fluoroscopy. A solution that helps interventionists diagnose, decide, guide, treat and confirm the success of PCI, with the potential to limit the use of iodinated contrast media.

Efficiency in the cath lab

  • Clearly identify coronary artery disease with imaging, physiology, co-registration and software available in one platform.
  • Perform tasks such as 2D-QA during fluoroscopy or exposure with instant parallel working functionality.
  • Make fast, informed clinical decisions by going beyond the angiogram to complete your view of the target vessel.
  • Continuously monitor patients and improve cath lab workflows with hemo monitoring and data management.

Improve end-to-end experiences

  • Easy access to applications and imaging tools to improve cath lab performance.
  • Solutions for every step of coronary procedures, from diagnosis to restoring vessel patency.
  • Scalable platform that will be ready to provide you with new innovations and tools as they become available in the future.

Dynamic Coronary Roadmap is a great asset to add to the interventional toolkit. It is an easy-to-use tool which reduces the contrast exposure to patients. It is very useful in patients with low GFR or patients with branch vessel disease. I use it very frequently to assist in decreasing contrast use.

Dr. Aaron Strobel
Dr. Aaron Strobel
Interventional Cardiologist
Baptist Health
Clinician performing interventional procedure using Dynamic Coronary Roadmap

Enabling technologies

  • Two clinicians viewing screens using ClarityIQ during interventional procedure.

    ClarityIQ technology delivers significantly lower dose across the clinical area, patients, and operators.

  • FlexArm exam room

    FlexArm ceiling-mounted system provides unlimited imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams.

Related procedures

Documentation

Coronary suite: Transforming complex PCI procedures into confident care 
PDF|(1.69 MB)

Improving patient care at Robert Bosch Hospital

See how Robert Bosch Hospital’s cardiac center implemented a multimodality imaging system, Philips Azurion with IntraSight, and enabled complex imaging.

Philips Azurion with IntraSight
Footnotes
  1. Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.
  2. Results obtained during usability study performed in December 2016. The study involved 33 participants. Participants were spread evenly over technologist/ nurses and physicians. To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by participants that had relevant working experience in the interventional lab and who had not previously used the new system. Data on File.
  3. Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59.
  4. Philips whitepaper 12nc 4522 991 30501; Reduction of procedure time by 17% with Philips Azurion in independently verified study;  https://www.usa.philips.com/healthcare/case-study/philips-azurion-lab-performance-study. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
  5. Co-registration tools available within InstraSight 7 configuration via SyncVision.
Disclaimer
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Products subject to country availability. Please contact your local sales representative.
Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.